Antagonism of the Transient Receptor Potential Melastatin-2 Channel Leads to Targeted Antitumor Effects in Primary Human Malignant Melanoma Cells

Researchers determined the effects of antagonism of the transient receptor potential melastatin‑2 ion channel in primary human malignant melanoma cells.